Status
Conditions
About
Evaluation of cost-effectiveness of FDG-PET for the public health system in Brazil.
Full description
To provide detailed information about cost and effectiveness of FDG-PET in multiple oncological diseases, such as Lymphoma, lung cancer and esophageal cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
500 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal